Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni B Frisoni

Showing results (421-430 of 524) with videos related to

Pageof 53
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementiaAnja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.
BMC Medical Informatics and Decision Making|December 8, 2022
Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network modelAmira Soliman, Jose R Chang, Kobra Etminani, et al.
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2021
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PETKobra Etminani, Amira Soliman, Anette Davidsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarianna Rizzo, Charlotte E Teunissen, Frederic Brosseron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisAurore Delvenne, Marianna Rizzo, Bailin Zhang, et al.
Pageof 53

Showing results (421-430 of 524) with videos related to

Sort By:
Pageof 53
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementiaAnja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.
BMC Medical Informatics and Decision Making|December 8, 2022
Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network modelAmira Soliman, Jose R Chang, Kobra Etminani, et al.
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2021
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PETKobra Etminani, Amira Soliman, Anette Davidsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarianna Rizzo, Charlotte E Teunissen, Frederic Brosseron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisAurore Delvenne, Marianna Rizzo, Bailin Zhang, et al.
Pageof 53